Controlling Out of Pocket (OOP) Expenses for Medicare Prescriptions While not directly related to CLL, this second FDA approved indication is another reason to anticipate that zanubrutinib will soon... September 27, 2021Business, Finances, Insurance & Regulatory, NewsBy Brad Hedrick
U.S. FDA Grants BRUKINSA® (Zanubrutinib) Accelerated Approval in Relapsed or Refractory Marginal Zone Lymphoma While not directly related to CLL, this second FDA approved indication is another reason to anticipate that zanubrutinib will soon... September 17, 2021Business, Finances, Insurance & Regulatory, NewsBy Brad Hedrick
Dr. Kerry Rogers on an Upcoming Phase I Clinical Trial of CDK9 Inhibitor VIP152 for Chronic Lymphocytic Leukemia (CLL) Dr. Brian Koffman spoke with Dr. Kerry Rogers, assistant professor and hematologist in the Division of Hematology at the Ohio... September 7, 2021News, News about Clinical TrialsBy Brad Hedrick
Chronic Lymphocytic Leukemia (CLL) Patient Tragically Dies From COVID-19 Due to Letting Guard Down After Being Fully Vaccinated We still have work to do, but for right now, let’s celebrate this major win for CLL and other immunocompromised... September 7, 2021C19 - Updates, COVID-19, NewsBy Brad Hedrick
U.S. FDA Grants BRUKINSA® (Zanubrutinib) Approval in Waldenström’s Macroglobulinemia on September 01, 2021 While not directly related to CLL, this second FDA approved indication is another reason to anticipate that zanubrutinib will soon... September 5, 2021Business, Finances, Insurance & Regulatory, NewsBy Brad Hedrick
Oral Parity: H.R. 4385 Could Lower Your CLL Drug Cost! Below is an appeal from Tom Henry, a pharmacist, CLL patient and longtime friend of the CLL community and the... August 27, 2021Business, Finances, Insurance & RegulatoryBy Brad Hedrick
CLL Society’s Official Statement on Boosters for CLL (Chronic Lymphocytic Leukemia) Patients CLL Society is encouraging all chronic lymphocytic leukemia patients who received the Moderna or Pfizer vaccines to promptly arrange for... August 21, 2021COVID-19, Official Statements and Press ReleasesBy Brad Hedrick
AZD7442 PROVENT Phase III Prophylaxis Trial Met Primary Endpoint in Preventing Symptomatic COVID-19 We still have work to do, but for right now, let’s celebrate this major win for CLL and other immunocompromised... August 20, 2021C19 - Updates, COVID-19, News, News about Clinical TrialsBy Brad Hedrick
Newsflash: FDA Authorizes Third Vaccine Dose for the Immunocompromised (8/15/21 Update) We still have work to do, but for right now, let’s celebrate this major win for CLL and other immunocompromised... August 13, 2021Business, Finances, Insurance & Regulatory, C19 - Updates, COVID-19By Brad Hedrick
COVID-19 Plan: Checklists for Chronic Lymphocytic Leukemia (CLL) Preparing for Pre and Post COVID-19 Exposure Explaining to Family and Friends Why the CDC Guidelines for Those Vaccinated Against COVID-19 Do Not Apply to Chronic Lymphocytic... July 26, 2021COVID-19, Official Statements and Press ReleasesBy Brad Hedrick
